TABLE 2.
Meaningful test methods and conditions for antifungal susceptibility testing
Organism | Drug | Methods | Interpretation | References |
---|---|---|---|---|
Candida spp. | Fluconazole | M27-A and methods that give concordant results | S, <8 μg/ml; S-DD, >8 μg/ml and ≤32 μg/ml; R, >32μg/ml; data are best supported for mucosal disease, but the general principles also appear to hold for invasive disease; adequate drug dose is critical as the MIC rises; C. krusei is assumed intrinsically resistant and should not be tested | 32, 108, 135, 182 |
Itraconazole | M27-A and methods that give concordant results | S, ≤0.125 μg/ml; S-DD; >0.125 μg/ml and ≤0.5 μg/ml; R, >0.5 μg/ml, data apply only to mucosal disease; ensuring adequate absorption by use of the solution is often critical to drug efficacy | 135, 182 | |
Ketoconazole | M27-A-like methods | No specific breakpoints proposed, but aggregate data suggest that isolates with an MIC of >0.125 μ/ml by M27-A are less likely to respond | 27, 123, 128, 191, 205 | |
Flucytosine | M27-A-like methods | S, ≤4 μg/ml; I, >4 μg/ml and ≤16 μg/ml; R, >16 μg/ml; these breakpoints are based largely on historical data and animal models but appear rational based on the available clinical and pharmacokinetic data | 7, 70, 89, 135 | |
Amphotericin B | M27-A-like methods that use AM3 broth, Etest, or MFC methods | Significant controversy and difficulty; agar-based methods appear to have the most potential, in general, and isolates with amphotericin B MICs of >0.5 μg/ml are probably resistant; specific breakpoints have NOT been proposed, and intralaboratory variation makes use of reference isolates with known resistance mandotory; fortunately, resistance appears uncommon among the four most common species (106) | 34, 137, 180, 221 | |
C. neoformans | Fluconazole | Modified M27-A (YNB broth, higher inoculum) | No specific breakpoints proposed; Data are limited but consistent: MICs of ≥2–4 μg/ml by this method appear to predict a greater chance of failure; failure definitely appears more likely as the MIC reaches 16 μg/ml | 1, 93; Witt et al., abstr. a |
Flucytosine | M27-A-like methods | No specific breakpoints proposed, but breakpoints similar to those for Candida spp. (see above) would appear rational | ||
Amphotericin B | M27-A-like methods that use AM3 broth, Etest | Significant controversy and difficulty; agar-based methods have the most potential in general. Measurement of fungicidal concentrations may have value; no specific breakpoints proposed—testing should incorporate reference isolates with known resistance. | 117, 185, 186 | |
Mold fungi | Any | Unknown | M38-like methods correlate for itraconazole and A. fumigatus; correlations for amphotericin B are ill-defined | See text |
M. D. Witt, L. A. Mortara, R. A. Larsen, R. J. Lewis, J. E. Edwards, and M. Ghannoun, Abstr. IXth Int. Coaf. AIDS, abstr. WS-B12-4, 1993.